| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.8M | +26.7% |
| Gross Profit | $6.8M | +499.7% |
| R&D Expense | $30.5M | -61.1% |
| SG&A Expense | $50.6M | -23.4% |
| Operating Income | -$192.3M | -651.1% |
| Pre-tax Income | -$196.3M | -1481.8% |
| Income Tax | $10K | -23.1% |
| Net Income | -$196.3M | -1483.1% |
| EPS (Basic) | -$11.02 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $227K | -98.4% |
| Accounts Receivable | $10.0M | +125.7% |
| Inventory | $5.8M | +8.4% |
| Current Assets | $19.8M | -40.9% |
| Total Assets | $143.9M | -64.1% |
| Current Liabilities | $67.3M | +8.4% |
| Total Liabilities | $102.9M | -49.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.7M | +71.9% |
| Capital Expenditures | $1.0M | -80.0% |
| Investing Cash Flow | -$4.0M | +22.7% |
| Financing Cash Flow | $24.1M | -79.9% |
| Free Cash Flow | -$39.7M | +72.2% |
| — |
| EPS (Diluted) | -$11.02 | — |
| Stockholders' Equity |
| $41.0M |
| -79.4% |